Why would men use finasteride in 2005?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s11918-005-0011-7.pdf
Reference10 articles.
1. McConnell JD, Bruskewitz R, Walsh P, et al.: The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-term Efficacy and Safety Study Group. N Engl J Med 1998, 38:557–563. Retraces the issues and areas of controversy for α-reductase drugs. Each development has spawned a new area of concern to be balanced against the established efficacy.
2. Roehrborn CG, Boyle P, Nickel JC, et al.: Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 2002, 60:434–441. Also retraces the issues and areas of controversy for a-reductase drugs. Each development has spawned a new area of concern to be balanced against the established efficacy.
3. Kaplan SA: Medical therapy for asymptomatic men with benign prostatic hyperplasia: primum non nocere. Urology 2003, 62:784–785.
4. Roehrborn CG: The clinical benefits of dutasteride for LUTS and BPH treatment. Rev Urol 2004, 6(suppl 9):822–830.
5. Debruyne F, Barkin J, van Erps P, et al.: Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia. Eur Urol 2004, 46:488–495.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3